Risk stratification in follicular neoplasm: A cytological assessment using the modified Bethesda classification

Berrin Ustun, David Chhieng, Alison Van Dyke, Tobias Carling, Elizabeth Holt, Robert Udelsman, Adebowale J. Adeniran

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

BACKGROUND: The 2007 Bethesda classification for thyroid cytology defines follicular neoplasm as a category of cases with cellular specimens demonstrating abundant follicular cells arranged in a microfollicular pattern with little or no colloid. The current recommendation for the management of these cases is diagnostic lobectomy. There has been great difficulty and variability in triaging and reporting follicular neoplasm. To increase diagnostic accuracy, at the study institution, this category is subclassified further into 3 categories: 1) microfollicular-patterned neoplasm (MN); 2) H€urthle cell neoplasm (HN); and 3) follicular lesion with some features suggestive of but not diagnostic of the follicular variant of papillary thyroid carcinoma (FL). The authors reviewed the cases of follicular neoplasm observed over a period of 5 years to document the follow-up trend using this modified classification. METHODS: A search of the cytology records was performed for the period between January 2008 and December 2012. All thyroid fine-needle aspiration cases were reviewed and those with a diagnosis of follicular neoplasm (including H€urthle cell neoplasm) were identified. Correlating follow-up surgical pathology reports were reviewed. RESULTS: A total of 399 cases of follicular neoplasm with surgical follow-up were identified. Malignancy was identified in 32% of all cases of follicular neoplasm and was found to be disproportionately higher in the FL category (73%). A cytological diagnosis of FL is more likely to be called malignant (73%) than benign neoplastic (9%) or benign nonneoplastic (18%). A cytological diagnosis of MN or HN is more likely to be benign neoplastic (46% and 46%, respectively) than malignant (29% and 26%, respectively) or benign nonneoplastic (25% and 28%, respectively). Of the cytological features examined, 2 (nuclear enlargement and nuclear grooves) were significantly associated with the follicular variant of papillary thyroid carcinoma. CONCLUSIONS: The results of the current study clearly indicate that follicular lesions with even subtle nuclear atypia have a high positive predictive value for malignancy and therefore should be distinguished from other follicular lesions because these cases require more aggressive surgical management. The current study also raises an important issue concerning the current thyroid classification based on the 2007 Bethesda classification for thyroid cytology. Future thyroid fine-needle aspiration classification schemes should consider subclassifying follicular neoplasms for the purpose of risk stratification.

Original languageEnglish (US)
Pages (from-to)536-545
Number of pages10
JournalCancer cytopathology
Volume122
Issue number7
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Neoplasms
Oxyphil Cells
Thyroid Gland
Cell Biology
Fine Needle Biopsy
Surgical Pathology
Case Management
Colloids

Keywords

  • Cytological diagnosis
  • Fine-needle aspiration
  • Follicular neoplasm
  • Hüurthle cell neoplasm
  • Papillary thyroid carcinoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Risk stratification in follicular neoplasm : A cytological assessment using the modified Bethesda classification. / Ustun, Berrin; Chhieng, David; Van Dyke, Alison; Carling, Tobias; Holt, Elizabeth; Udelsman, Robert; Adeniran, Adebowale J.

In: Cancer cytopathology, Vol. 122, No. 7, 2014, p. 536-545.

Research output: Contribution to journalArticle

Ustun, B, Chhieng, D, Van Dyke, A, Carling, T, Holt, E, Udelsman, R & Adeniran, AJ 2014, 'Risk stratification in follicular neoplasm: A cytological assessment using the modified Bethesda classification', Cancer cytopathology, vol. 122, no. 7, pp. 536-545. https://doi.org/10.1002/cncy.21425
Ustun, Berrin ; Chhieng, David ; Van Dyke, Alison ; Carling, Tobias ; Holt, Elizabeth ; Udelsman, Robert ; Adeniran, Adebowale J. / Risk stratification in follicular neoplasm : A cytological assessment using the modified Bethesda classification. In: Cancer cytopathology. 2014 ; Vol. 122, No. 7. pp. 536-545.
@article{91733940afed4225a8a51a2dfc731947,
title = "Risk stratification in follicular neoplasm: A cytological assessment using the modified Bethesda classification",
abstract = "BACKGROUND: The 2007 Bethesda classification for thyroid cytology defines follicular neoplasm as a category of cases with cellular specimens demonstrating abundant follicular cells arranged in a microfollicular pattern with little or no colloid. The current recommendation for the management of these cases is diagnostic lobectomy. There has been great difficulty and variability in triaging and reporting follicular neoplasm. To increase diagnostic accuracy, at the study institution, this category is subclassified further into 3 categories: 1) microfollicular-patterned neoplasm (MN); 2) H€urthle cell neoplasm (HN); and 3) follicular lesion with some features suggestive of but not diagnostic of the follicular variant of papillary thyroid carcinoma (FL). The authors reviewed the cases of follicular neoplasm observed over a period of 5 years to document the follow-up trend using this modified classification. METHODS: A search of the cytology records was performed for the period between January 2008 and December 2012. All thyroid fine-needle aspiration cases were reviewed and those with a diagnosis of follicular neoplasm (including H€urthle cell neoplasm) were identified. Correlating follow-up surgical pathology reports were reviewed. RESULTS: A total of 399 cases of follicular neoplasm with surgical follow-up were identified. Malignancy was identified in 32{\%} of all cases of follicular neoplasm and was found to be disproportionately higher in the FL category (73{\%}). A cytological diagnosis of FL is more likely to be called malignant (73{\%}) than benign neoplastic (9{\%}) or benign nonneoplastic (18{\%}). A cytological diagnosis of MN or HN is more likely to be benign neoplastic (46{\%} and 46{\%}, respectively) than malignant (29{\%} and 26{\%}, respectively) or benign nonneoplastic (25{\%} and 28{\%}, respectively). Of the cytological features examined, 2 (nuclear enlargement and nuclear grooves) were significantly associated with the follicular variant of papillary thyroid carcinoma. CONCLUSIONS: The results of the current study clearly indicate that follicular lesions with even subtle nuclear atypia have a high positive predictive value for malignancy and therefore should be distinguished from other follicular lesions because these cases require more aggressive surgical management. The current study also raises an important issue concerning the current thyroid classification based on the 2007 Bethesda classification for thyroid cytology. Future thyroid fine-needle aspiration classification schemes should consider subclassifying follicular neoplasms for the purpose of risk stratification.",
keywords = "Cytological diagnosis, Fine-needle aspiration, Follicular neoplasm, H{\"u}urthle cell neoplasm, Papillary thyroid carcinoma",
author = "Berrin Ustun and David Chhieng and {Van Dyke}, Alison and Tobias Carling and Elizabeth Holt and Robert Udelsman and Adeniran, {Adebowale J.}",
year = "2014",
doi = "10.1002/cncy.21425",
language = "English (US)",
volume = "122",
pages = "536--545",
journal = "Cancer cytopathology",
issn = "1934-662X",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Risk stratification in follicular neoplasm

T2 - A cytological assessment using the modified Bethesda classification

AU - Ustun, Berrin

AU - Chhieng, David

AU - Van Dyke, Alison

AU - Carling, Tobias

AU - Holt, Elizabeth

AU - Udelsman, Robert

AU - Adeniran, Adebowale J.

PY - 2014

Y1 - 2014

N2 - BACKGROUND: The 2007 Bethesda classification for thyroid cytology defines follicular neoplasm as a category of cases with cellular specimens demonstrating abundant follicular cells arranged in a microfollicular pattern with little or no colloid. The current recommendation for the management of these cases is diagnostic lobectomy. There has been great difficulty and variability in triaging and reporting follicular neoplasm. To increase diagnostic accuracy, at the study institution, this category is subclassified further into 3 categories: 1) microfollicular-patterned neoplasm (MN); 2) H€urthle cell neoplasm (HN); and 3) follicular lesion with some features suggestive of but not diagnostic of the follicular variant of papillary thyroid carcinoma (FL). The authors reviewed the cases of follicular neoplasm observed over a period of 5 years to document the follow-up trend using this modified classification. METHODS: A search of the cytology records was performed for the period between January 2008 and December 2012. All thyroid fine-needle aspiration cases were reviewed and those with a diagnosis of follicular neoplasm (including H€urthle cell neoplasm) were identified. Correlating follow-up surgical pathology reports were reviewed. RESULTS: A total of 399 cases of follicular neoplasm with surgical follow-up were identified. Malignancy was identified in 32% of all cases of follicular neoplasm and was found to be disproportionately higher in the FL category (73%). A cytological diagnosis of FL is more likely to be called malignant (73%) than benign neoplastic (9%) or benign nonneoplastic (18%). A cytological diagnosis of MN or HN is more likely to be benign neoplastic (46% and 46%, respectively) than malignant (29% and 26%, respectively) or benign nonneoplastic (25% and 28%, respectively). Of the cytological features examined, 2 (nuclear enlargement and nuclear grooves) were significantly associated with the follicular variant of papillary thyroid carcinoma. CONCLUSIONS: The results of the current study clearly indicate that follicular lesions with even subtle nuclear atypia have a high positive predictive value for malignancy and therefore should be distinguished from other follicular lesions because these cases require more aggressive surgical management. The current study also raises an important issue concerning the current thyroid classification based on the 2007 Bethesda classification for thyroid cytology. Future thyroid fine-needle aspiration classification schemes should consider subclassifying follicular neoplasms for the purpose of risk stratification.

AB - BACKGROUND: The 2007 Bethesda classification for thyroid cytology defines follicular neoplasm as a category of cases with cellular specimens demonstrating abundant follicular cells arranged in a microfollicular pattern with little or no colloid. The current recommendation for the management of these cases is diagnostic lobectomy. There has been great difficulty and variability in triaging and reporting follicular neoplasm. To increase diagnostic accuracy, at the study institution, this category is subclassified further into 3 categories: 1) microfollicular-patterned neoplasm (MN); 2) H€urthle cell neoplasm (HN); and 3) follicular lesion with some features suggestive of but not diagnostic of the follicular variant of papillary thyroid carcinoma (FL). The authors reviewed the cases of follicular neoplasm observed over a period of 5 years to document the follow-up trend using this modified classification. METHODS: A search of the cytology records was performed for the period between January 2008 and December 2012. All thyroid fine-needle aspiration cases were reviewed and those with a diagnosis of follicular neoplasm (including H€urthle cell neoplasm) were identified. Correlating follow-up surgical pathology reports were reviewed. RESULTS: A total of 399 cases of follicular neoplasm with surgical follow-up were identified. Malignancy was identified in 32% of all cases of follicular neoplasm and was found to be disproportionately higher in the FL category (73%). A cytological diagnosis of FL is more likely to be called malignant (73%) than benign neoplastic (9%) or benign nonneoplastic (18%). A cytological diagnosis of MN or HN is more likely to be benign neoplastic (46% and 46%, respectively) than malignant (29% and 26%, respectively) or benign nonneoplastic (25% and 28%, respectively). Of the cytological features examined, 2 (nuclear enlargement and nuclear grooves) were significantly associated with the follicular variant of papillary thyroid carcinoma. CONCLUSIONS: The results of the current study clearly indicate that follicular lesions with even subtle nuclear atypia have a high positive predictive value for malignancy and therefore should be distinguished from other follicular lesions because these cases require more aggressive surgical management. The current study also raises an important issue concerning the current thyroid classification based on the 2007 Bethesda classification for thyroid cytology. Future thyroid fine-needle aspiration classification schemes should consider subclassifying follicular neoplasms for the purpose of risk stratification.

KW - Cytological diagnosis

KW - Fine-needle aspiration

KW - Follicular neoplasm

KW - Hüurthle cell neoplasm

KW - Papillary thyroid carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84906889811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906889811&partnerID=8YFLogxK

U2 - 10.1002/cncy.21425

DO - 10.1002/cncy.21425

M3 - Article

C2 - 24753500

AN - SCOPUS:84906889811

VL - 122

SP - 536

EP - 545

JO - Cancer cytopathology

JF - Cancer cytopathology

SN - 1934-662X

IS - 7

ER -